You may have reached this page due to new security upgrades that have been implemented regarding multiple user logins. For security reasons, only one user is able to be signed in to an account per session. If multiple users at a single site need online access, please contact email@example.com for firm access reduced pricing. If, however, you believe your login information has been compromised, please call customer service at 1-800-451-9998 to determine how to reset your password. Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.
Biotech may be booming, but numbers hard to come by
By Sam Boykin CHARLOTTE — With resources like the N.C. Research Campus, a major university, an international airport and an active community of business leaders and entrepreneurs, Charlotte is well poised to tap into the growing biotechnology industry. But according to Simon Pedder, it also lacks key ingredients like a research-based medical facility and a reliable funding source for start-up biotech companies. Pedder, CEO and founder of Chelsea Therapeutics International Inc., a Charlotte biopharmaceutical development company, spoke at last week’s Eighth Annual Charlotte Biotechnology Conference at UNC Charlotte.